{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:02:59Z","timestamp":1761973379890,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A092258"],"award-info":[{"award-number":["A092258"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.exer.2012.11.021","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T21:52:35Z","timestamp":1354830755000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of subconjunctival ranibizumab in a presensitized rat model of corneal graft"],"prefix":"10.1016","volume":"107","author":[{"given":"Kyong Jin","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Sub","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choun-Ki","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2012.11.021_bib1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.exer.2012.11.021_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exer.2012.11.021_bib3","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1167\/iovs.05-0105","article-title":"Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis","volume":"46","author":"Andrieu-Soler","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularized rejected corneal grafts","volume":"33","author":"Awadein","year":"2007","journal-title":"Journal of Cataract and Refractive Surgery"},{"key":"10.1016\/j.exer.2012.11.021_bib5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":"Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation","volume":"126","author":"Bachmann","year":"2008","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","article-title":"Vascular endothelial growth factor biology: clinical implications for ocular treatments","volume":"90","author":"Bhisitkul","year":"2006","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib8","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1158\/0008-5472.CAN-04-2345","article-title":"Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis","volume":"65","author":"Bjorndahl","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.exer.2012.11.021_bib9","first-page":"1461","article-title":"Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats","volume":"12","author":"Bourges","year":"2006","journal-title":"Molecular Vision"},{"key":"10.1016\/j.exer.2012.11.021_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/8379","article-title":"Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188","volume":"5","author":"Carmeliet","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.exer.2012.11.021_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"Chen","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The impact of corneal allograft rejection on the long-term outcome of corneal transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib13","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib14","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.exer.2012.11.021_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib16","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":"Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival","volume":"51","author":"Dastjerdi","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib17","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.exer.2012.11.021_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2353\/ajpath.2010.080642","article-title":"Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in\u00a0vivo","volume":"176","author":"Ebrahem","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.exer.2012.11.021_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jcb.240470305","article-title":"The vascular endothelial growth factor family of polypeptides","volume":"47","author":"Ferrara","year":"1991","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.exer.2012.11.021_bib20","first-page":"729","article-title":"Corneal epithelial rejection in the rat","volume":"43","author":"Figueiredo","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/ICU.0b013e3282fb7c33","article-title":"Polypoidal choroidal vasculopathy and treatments","volume":"19","author":"Gomi","year":"2008","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-9071.2010.02252.x","article-title":"Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone","volume":"38","author":"Hoffart","year":"2010","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00003226-199109000-00003","article-title":"Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model","volume":"10","author":"Holland","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2012.11.021_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1096\/fj.03-1179fje","article-title":"VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins","volume":"18","author":"Hong","year":"2004","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.exer.2012.11.021_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2012.11.021_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.20010838","article-title":"Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts","volume":"195","author":"Liu","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.exer.2012.11.021_bib27","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)","volume":"91","author":"Manzano","year":"2007","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib29","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.exer.2012.11.021_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/019262339902700507","article-title":"Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration","volume":"27","author":"Mordenti","year":"1999","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.exer.2012.11.021_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.20021244","article-title":"Vascular permeability factor\/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis","volume":"196","author":"Nagy","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.exer.2012.11.021_bib32","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1172\/JCI6740","article-title":"VEGF(165) mediates glomerular endothelial repair","volume":"104","author":"Ostendorf","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.exer.2012.11.021_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.exer.2012.11.021_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00347-009-1934-0","article-title":"Topical inhibition of angiogenesis at the cornea. Safety and efficacy","volume":"106","author":"Regenfuss","year":"2009","journal-title":"Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft"},{"key":"10.1016\/j.exer.2012.11.021_bib36","first-page":"104","article-title":"Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes","volume":"17","author":"Rocher","year":"2011","journal-title":"Molecular Vision"},{"key":"10.1016\/j.exer.2012.11.021_bib37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/02713683.2011.601840","article-title":"The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model","volume":"36","author":"Sener","year":"2011","journal-title":"Current Eye Research"},{"key":"10.1016\/j.exer.2012.11.021_bib38","first-page":"427","article-title":"Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice","volume":"36","author":"Sonoda","year":"1995","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.exer.2012.11.021_bib39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4049\/jimmunol.150.5.1727","article-title":"Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts","volume":"150","author":"Sonoda","year":"1993","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.exer.2012.11.021_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.exer.2012.11.021_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ICO.0b013e3181ba0ae2","article-title":"Corneal graft surgery combined with subconjunctival bevacizumab (avastin)","volume":"29","author":"Symes","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2012.11.021_bib42","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","article-title":"Avastin use in high risk corneal transplantation","volume":"247","author":"Vassileva","year":"2009","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie)"},{"key":"10.1016\/j.exer.2012.11.021_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0161-6420(92)31960-8","article-title":"Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry","volume":"99","author":"Williams","year":"1992","journal-title":"Ophthalmology"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483512003521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483512003521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:55:12Z","timestamp":1757998512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483512003521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":43,"alternative-id":["S0014483512003521"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2012.11.021","relation":{},"ISSN":["0014-4835"],"issn-type":[{"type":"print","value":"0014-4835"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of subconjunctival ranibizumab in a presensitized rat model of corneal graft","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2012.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}